Sacha Gnjatic

68PUBLICATIONS
657CO-AUTHORS
Predictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|Apr 19, 2026
Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial.

|Feb 26, 2026
A Tumor-Promoting Inflammatory SPP1+ Macrophage-IL6-CRP Axis Drives Immune Dysfunction in Bladder Cancer.

Michelle A Tran, Byuri Angela Cho, Sudeh Izadmehr

|Feb 11, 2026
Integrated histopathology of the human pancreas throughout stages of type 1 diabetes progression.

Verena van der Heide, Sara McArdle, Michael S Nelson

|Jan 27, 2026
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade.

Edgar Gonzalez-Kozlova, Robert Sweeney, Igor Figueiredo

Pageof 12